BFG
MAIA icon

Bleakley Financial Group’s MAIA Biotechnology MAIA Stock Holding History

Bleakley Financial Group’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Buy
+181,623
New +$241K ﹤0.01% 900

Other funds holding MAIA

CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
CAG
Centerpoint Advisory Group Overland Park, Kansas $158M AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM

Bleakley Financial Group's MAIA Position: Q2 2026 in Review

Bleakley Financial Group opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 181,623 shares worth $262K. The stake represents ﹤0.01% of the portfolio and ranks #900 among its holdings.

13 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Bleakley Financial Group held 181,623 shares of MAIA Biotechnology worth $262K as of Q2 2026.
  • MAIA Biotechnology was a new Bleakley Financial Group position in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Bleakley Financial Group's portfolio in Q2 2026, its #900 holding.
  • 13 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.